Prognostic potential of a PSA complex in sera of prostate cancer patients with alpha2-macroglobulin deficiency. (Q33351349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Prognostic potential of a PSA complex in sera of prostate cancer patients with alpha2-macroglobulin deficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Yuhsaku Kanoh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tadashi Ohara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Shin Egawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Shiro Baba

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tohru Akahoshi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Laboratory Analysis

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

302-306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas

10 January 2020

cites work

1 reference

12 December 2020

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

12 December 2020

Usefulness of alpha1-antichymotrypsin-PSA complex for predicting bone metastases of prostate cancer

1 reference

12 December 2020

Identification of alpha 2-macroglobulin as a carrier protein for IL-6

1 reference

12 December 2020

Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels

1 reference

12 December 2020

Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera.

1 reference

12 December 2020

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

12 December 2020

Human prostate-specific antigen: structural and functional similarity with serine proteases

1 reference

12 December 2020

Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer

1 reference

12 December 2020

[Studies on alpha 2 macroglobulin deficiency in association with cancer metastasis]

1 reference

12 December 2020

Serum protease inhibitors in the blood clearance of subtilisin A

1 reference

12 December 2020

Progression of prostate cancer: diagnostic and prognostic utility of prostate-specific antigen, alpha2-macroglobulin, and their complexes

1 reference

12 December 2020

Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays

1 reference

12 December 2020

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer

1 reference

12 December 2020

The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience

1 reference

12 December 2020

Alpha-2-macroglobulin deficiency in patients with advanced prostate cancer

1 reference

12 December 2020

Biological activity of prostate‐specific antigen isolated by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis and electroelution

1 reference

12 December 2020

Identification of transformed alpha 2-macroglobulin as a growth hormone-binding protein in human blood

1 reference

12 December 2020

Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin

1 reference

12 December 2020

Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?

1 reference

12 December 2020

Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer

1 reference

12 December 2020

Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications

1 reference

12 December 2020

Identifiers

DOI

10.1002/JCLA.20260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18623104%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference